Comprehensive Omics Analysis Uncovers Alterations in Sphingolipid Metabolism of Tumor-Influenced MDSCs in Cervical Cancer

Category	Detail
Condition	Cervical Cancer
Key Mechanisms	Alterations in sphingolipid metabolism in tumor-influenced myeloid-derived suppressor cells (MDSCs)
Target Population	Females diagnosed with cervical cancer
Care Setting	Tumor microenvironment analysis

MDSCs significantly influence disease progression and immune evasion in cervical cancer.
Expansion of MDSCs correlates positively with tumor burden and negatively with therapy response.
Metabolic reprogramming of MDSCs is crucial for their function and survival in the tumor microenvironment.
Sphingolipid metabolism is notably altered in MDSCs from cervical cancer patients.
Kng1–sphingosine 1-phosphate identified as a key protein–metabolite network in MDSCs.

Pathological confirmation of cervical squamous cell carcinoma, adenocarcinoma, or adenosquamous carcinoma.

Assessment of MDSC frequencies in relation to tumor burden and therapy response.

Patients with cervical cancer undergoing radical hysterectomy and lymph node dissection.

No prior radiotherapy or chemotherapy before surgery.

Utilize immune cell infiltration scoring systems for better prognosis prediction.
Investigate metabolic alterations in MDSCs for potential therapeutic targets.

Clinical Scorecard: Comprehensive Omics Analysis Uncovers Alterations in Sphingolipid Metabolism of Tumor-Influenced MDSCs in Cervical Cancer